Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$0.38 - $0.89 $14 - $33
-38 Reduced 0.08%
49,385 $40,000
Q1 2022

May 04, 2022

BUY
$0.58 - $0.86 $8,700 - $12,900
15,000 Added 43.58%
49,423 $29,000
Q4 2021

Jan 31, 2022

SELL
$0.73 - $1.28 $7,665 - $13,440
-10,500 Reduced 23.37%
34,423 $28,000
Q3 2021

Oct 29, 2021

BUY
$0.77 - $4.91 $26,372 - $168,167
34,250 Added 320.9%
44,923 $35,000
Q2 2021

Aug 11, 2021

SELL
$2.18 - $4.66 $3,270 - $6,990
-1,500 Reduced 12.32%
10,673 $49,000
Q1 2021

May 04, 2021

BUY
$1.3 - $3.24 $15,824 - $39,440
12,173 New
12,173 $31,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.